Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
HighPeak Energy
HPK
$947M
| $411K | ﹤0.01% |
41,888
+23,181
| +124% | +$229K |
|
3802
Stoneridge
SRI
$201M
| $410K | ﹤0.01% |
58,206
-13,158
| -18% | -$64.4K |
|
3803
Bausch Health
BHC
$2.37B
| $409K | ﹤0.01% |
61,408
+2,091
| +4% | +$10.7K |
|
3804
Blue Ridge Bankshares
BRBS
$336M
| $408K | ﹤0.01% |
113,624
+70,036
| +161% | +$236K |
|
3805
Primis Financial Corp
FRST
$413M
| $407K | ﹤0.01% |
37,532
+12,881
| +52% | +$119K |
|
3806
Westrock Coffee
WEST
$820M
| $406K | ﹤0.01% |
70,868
+23,733
| +50% | +$153K |
|
3807
Liberty Broadband Class A
LBRDA
$5.29B
| $405K | ﹤0.01% |
4,143
-4,987
| -55% | -$442K |
|
|
OLPX
3808
DELISTED
Olaplex Holdings
OLPX
| $405K | ﹤0.01% |
289,356
+96,440
| +50% | +$126K |
|
3809
eGain
EGAN
$206M
| $404K | ﹤0.01% |
64,688
+12,841
| +25% | +$68.7K |
|
3810
Kopin
KOPN
$898M
| $404K | ﹤0.01% |
263,852
+261,022
| +9,223% | +$340K |
|
|
REFI
3811
Chicago Atlantic Real Estate Finance
REFI
$264M
| $403K | ﹤0.01% |
28,863
+11,380
| +65% | +$163K |
|
|
MCHB
3812
Mechanics Bancorp
MCHB
$3.79B
| $402K | ﹤0.01% |
30,777
+12,394
| +67% | +$149K |
|
3813
KB Financial Group
KB
$41.7B
| $402K | ﹤0.01% |
4,870
-12,872
| -73% | -$870K |
|
3814
LifeVantage
LFVN
$81.9M
| $401K | ﹤0.01% |
30,674
+3,054
| +11% | +$39.5K |
|
3815
Asure Software
ASUR
$251M
| $401K | ﹤0.01% |
41,057
+16,589
| +68% | +$160K |
|
3816
Innoviz Technologies
INVZ
$114M
| $400K | ﹤0.01% |
+243,667
| New | +$213K |
|
|
SION
3817
Sionna Therapeutics
SION
$296M
| $399K | ﹤0.01% |
+23,022
| New | +$302K |
|
|
CIO
3818
DELISTED
City Office REIT
CIO
| $395K | ﹤0.01% |
73,947
+27,218
| +58% | +$136K |
|
3819
CALL
Nasdaq
NDAQ
$54.6B
| $393K | ﹤0.01% |
+4,400
| New | +$351K |
|
|
SSII
3820
SS Innovations International
SSII
$767M
| $393K | ﹤0.01% |
+66,759
| New | +$505K |
|
|
ARES.PRB
3821
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.41B
| $392K | ﹤0.01% |
7,399
-154,944
| -95% | -$7.82M |
|
3822
John Marshall Bancorp
JMSB
$328M
| $392K | ﹤0.01% |
21,148
+8,548
| +68% | +$144K |
|
3823
Hamilton Beach Brands
HBB
$447M
| $391K | ﹤0.01% |
21,873
+4,179
| +24% | +$74.2K |
|
3824
Entrada Therapeutics
TRDA
$290M
| $390K | ﹤0.01% |
58,082
+18,431
| +46% | +$148K |
|
3825
ADC Therapeutics
ADCT
$134M
| $390K | ﹤0.01% |
145,407
+44,373
| +44% | +$93.3K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.